The AP-1 transcription factor regulates postnatal mammary gland development.

The AP-1 transcription factor is activated by multiple growth factors that are critical regulators of breast cell proliferation. We previously demonstrated that AP-1 blockade inhibits breast cancer cell growth in vitro. Yet a specific role of AP-1 in normal mammary gland development has not been studied. Using a bi-transgenic mouse expressing an inducible AP-1 inhibitor (Tam67), we found that the AP-1 factor regulates postnatal proliferation of mammary epithelial cells. Mammary epithelial proliferation was significantly reduced after AP-1 blockade in adult, prepubertal, pubertal, and hormone-stimulated mammary glands. In pubertal mice, mammary cell proliferation was greatly reduced, and the cells that did proliferate failed to express Tam67. We also observed structural changes such as suppressed branching and budding, reduced gland tree size, and less fat pad occupancy in developing mammary glands after AP-1 blockade. We further demonstrated that Tam67 suppressed the expression of AP-1-dependent genes (TIMP-1, vimentin, Fra-1, and fibronectin) and the AP-1-dependent growth regulatory genes (cyclin D1 and c-myc) in AP-1-blocked mammary glands. We therefore conclude that AP-1 factor is a pivotal regulator of postnatal mammary gland growth and development.

[1]  M. D'urso,et al.  Characterization of the human STAT5A and STAT5B promoters: evidence of a positive and negative mechanism of transcriptional regulation , 2004, FEBS letters.

[2]  J. Wysolmerski,et al.  Absence of functional type 1 parathyroid hormone (PTH)/PTH-related protein receptors in humans is associated with abnormal breast development and tooth impaction. , 2001, The Journal of clinical endocrinology and metabolism.

[3]  E. Wagner,et al.  AP-1 in mouse development and tumorigenesis , 2001, Oncogene.

[4]  M. Karin,et al.  Antitumor promotion by phenolic antioxidants: inhibition of AP-1 activity through induction of Fra expression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[5]  T. Graubert,et al.  Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. , 2002, Developmental biology.

[6]  J. Thiery,et al.  Role of FGF10/FGFR2b signaling during mammary gland development in the mouse embryo. , 2002, Development.

[7]  B. Spiegelman,et al.  A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture. , 1993, Genes & development.

[8]  J. Martial,et al.  Inhibition of protein phosphatase PP1 in GH3B6, but not in GH3 cells, activates the MEK/ERK/c-fos pathway and the human prolactin promoter, involving the coactivator CPB/p300. , 2001, Molecular endocrinology.

[9]  E. Wagner,et al.  Embryonic stem (ES) cells lacking functional c-jun: consequences for growth and differentiation, AP-1 activity and tumorigenicity. , 1992, Oncogene.

[10]  A. Howell,et al.  The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone. , 1995, Endocrinology.

[11]  James A. Clark,et al.  Induction of Mammary Gland Development in Estrogen Receptor-α Knockout Mice. , 2000, Endocrinology.

[12]  M. Karin,et al.  The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. , 1991, Biochimica et biophysica acta.

[13]  Frank Hilberg,et al.  Functions of c-Jun in Liver and Heart Development , 1999, The Journal of cell biology.

[14]  Z. Werb,et al.  Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development. , 1999, Development.

[15]  M. Birrer,et al.  Mechanism of action of a dominant-negative mutant of c-Jun. , 1994, Oncogene.

[16]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[17]  L. Hennighausen,et al.  Signaling pathways in mammary gland development. , 2001, Developmental cell.

[18]  M. Karin,et al.  Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun , 1989, Cell.

[19]  R. Weinberg,et al.  Prolactin controls mammary gland development via direct and indirect mechanisms. , 1999, Developmental biology.

[20]  G. Dontu,et al.  Stem cells in normal breast development and breast cancer , 2003, Breast Cancer Research.

[21]  N. Colburn,et al.  Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  U. Thorgeirsson,et al.  Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. , 1992, Invasion & metastasis.

[23]  R. Johnson,et al.  c‐Jun regulates cell cycle progression and apoptosis by distinct mechanisms , 1999, The EMBO journal.

[24]  J. Helber,et al.  Hormone/growth factor interactions mediating epithelial/stromal communication in mammary gland development and carcinogenesis , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[25]  E. Wagner,et al.  Control of cell cycle progression by c-Jun is p53 dependent. , 1999, Genes & development.

[26]  S. Hilsenbeck,et al.  Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth , 2002, Oncogene.

[27]  J. Rosen,et al.  C/EBPβ (CCAAT/Enhancer Binding Protein) Controls Cell Fate Determination during Mammary Gland Development , 2000 .

[28]  J C Reed,et al.  Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis. , 1996, Development.

[29]  J. Thiery,et al.  Identification of the mammary line in mouse by Wnt10b expression , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.

[30]  B. Lanske,et al.  Rescue of the parathyroid hormone-related protein knockout mouse demonstrates that parathyroid hormone-related protein is essential for mammary gland development. , 1998, Development.

[31]  J. Martial,et al.  Transcription factor AP1 is involved in basal and okadaic acid-stimulated activity of the human PRL promoter. , 1998, Molecular endocrinology.

[32]  W. Ruan,et al.  IGF-I: An Essential Factor in Terminal End Bud Formation and Ductal Morphogenesis , 2004, Journal of Mammary Gland Biology and Neoplasia.

[33]  L. Rubin,et al.  A c-jun dominant negative mutant protects sympathetic neurons against programmed cell death , 1995, Neuron.

[34]  E. Wagner,et al.  Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation , 1999, Nature Genetics.

[35]  F. DeMayo,et al.  Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. , 2000, Science.

[36]  D. Rimm,et al.  Parathyroid hormone-related protein maintains mammary epithelial fate and triggers nipple skin differentiation during embryonic breast development. , 2001, Development.

[37]  A. Nardulli,et al.  Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site. , 2004, Molecular endocrinology.

[38]  B. Welm,et al.  Isolation and characterization of functional mammary gland stem cells , 2003, Cell proliferation.

[39]  P. Herrlich,et al.  12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5'-flanking region , 1987, Molecular and cellular biology.

[40]  P. Brown,et al.  The retinoic acid receptor antagonist, BMS453, inhibits normal breast cell growth by inducing active TGFβ and causing cell cycle arrest , 2001, Oncogene.

[41]  P. Kelly,et al.  Mammary Gland Development in Prolactin Receptor Knockout Mice , 1997, Journal of Mammary Gland Biology and Neoplasia.

[42]  L. Hennighausen,et al.  Parathyroid hormone-related protein signaling is necessary for sexual dimorphism during embryonic mammary development. , 1999, Development.

[43]  James A. Clark,et al.  Mammary Gland Development in Adult Mice Requires Epithelial and Stromal Estrogen Receptor α. , 2002, Endocrinology.

[44]  F. Kittrell,et al.  Establishment of Mouse Mammary Cell Lines , 2000 .

[45]  S. Hilsenbeck,et al.  Global gene expression analysis of estrogen receptor transcription factor cross talk in breast cancer: identification of estrogen-induced/activator protein-1-dependent genes. , 2005, Molecular endocrinology.

[46]  A. Nienhuis,et al.  Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[47]  K. Korach,et al.  Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. , 1996, Recent progress in hormone research.

[48]  S. Hilsenbeck,et al.  AP-1 blockade inhibits the growth of normal and malignant breast cells , 2001, Oncogene.

[49]  Qiang Shen,et al.  AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity , 2004, Oncogene.

[50]  Robert B Boxer,et al.  A novel doxycycline‐inducible system for the transgenic analysis of mammary gland biology , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[51]  L. Matrisian,et al.  Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of proto-oncogenes c-fos and c-jun and activation of protein kinase C , 1990, Molecular and cellular biology.

[52]  M. Birrer,et al.  Suppression of oncogene-induced transformation by a deletion mutant of c-jun. , 1993, Oncogene.

[53]  L. Matrisian.  Matrix Metalloproteinase Gene Expression a , 1994, Annals of the New York Academy of Sciences.

[54]  D. Hadsell,et al.  Targeted disruption of the IGF-I receptor gene decreases cellular proliferation in mammary terminal end buds. , 2001, Endocrinology.

[55]  J. Minna,et al.  jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun , 1989, Cell.

[56]  L. Hennighausen,et al.  Think globally, act locally: the making of a mouse mammary gland. , 1998, Genes & development.

[57]  S. Elledge,et al.  Cyclin D1 provides a link between development and oncogenesis in the retina and breast , 1995, Cell.

[58]  N. Colburn,et al.  Promising molecular targets for cancer prevention: AP-1, NF-κB and Pdcd4 , 2003 .

[59]  J. Tentler,et al.  Structural and functional analysis of the differential effects of c-Jun and v-Jun on prolactin gene expression. , 2004, Molecular endocrinology.

[60]  M. Birrer,et al.  The role of jun and fos gene family members in 12-O-tetradecanoylphorbol-13-acetate induced hemopoietic differentiation. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[61]  J. Martial,et al.  Far Upstream Sequences Regulate the Human Prolactin Promoter Transcription , 2000, Neuroendocrinology.

[62]  E. Wagner,et al.  c-Jun is essential for normal mouse development and hepatogenesis , 1993, Nature.

[63]  A. Nardulli,et al.  Estrogen Receptor α and Activating Protein-1 Mediate Estrogen Responsiveness of the Progesterone Receptor Gene in MCF-7 Breast Cancer Cells , 2002 .

[64]  C. Weerdt,et al.  EGF stimulates Pit-1 independent transcription of the human prolactin pituitary promoter in human breast cancer SK-BR-3 cells through its proximal AP-1 response element , 2005, Molecular and Cellular Endocrinology.